CMB 1.22% 41.5¢ cambium bio limited

Ann: Regeneus and Kyocera sign Progenza OA deal, page-14

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 448 Posts.
    lightbulb Created with Sketch. 240
    Well I have to admit that Leo has righted the ship and pulled off a better deal than I had thought likely. While I sold a few on the open this morning, I think things now look bright enough to hold the remainder into the medium term.

    So we have $11 million coming into the kick immediately, and presumably what’s left of the $2 million already received will be used to repay what has been used to date from the loans previously stumped up by Leo Lee and Barry Sechos.

    One thing that may need to be clarified is exactly what is meant by “Regeneus will receive single to high double digit royalties on all future OA product sales in Japan...”. I’m guessing this refers to percentages of each OA product sale in Japan, but it seems to be worth clarifying.

    It does seem reflective of the level of interest in Progenza from Kyocera that it has sought and gained right of first refusal for Progenza indications other than OA, inside and outside Japan.

    zeno9
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
41.5¢
Change
0.005(1.22%)
Mkt cap ! $4.891M
Open High Low Value Volume
41.5¢ 41.5¢ 41.5¢ $217 523

Buyers (Bids)

No. Vol. Price($)
1 11 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 24 1
View Market Depth
Last trade - 10.02am 11/11/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.